Arestat™ Protein Stabilisation Technology
Arestat™ comprises two fundamentally different aspects of our platform stabilisation technology – Arestat-T™ and Arestat-R™. Both utilise excipients and buffers approved by the FDA and EMEA in an unconventional manner to achieve the desired stability.
Arestat™
Stabilises biologics by controlling the rate of interactions with surrounding molecules.
Arestat™ summary
Arestat-T™ & Arestat-C™
Stabilises biologics in storage at refrigerated, ambient and elevated temperatures.
Proton exchange Metal ion interactions Hydrophobic interactions Control of hydrolysis
Arestat-R™
Stabilises biologics during and after sterilisation by a standard dose of ionising radiation.
Ionising radiation
Both are available for licensing for therapeutic proteins, vaccines, medial devices and diagnostics.
Case Studies
Application of Arestat™ formulations are illustrated in the case studies selected from Arecor’s in-house projects and several partnered projects.
Careers
Arecor is a rapidly expanding company and positions updates constantly appear.
To apply

If you enjoy working in a busy environment and would like to have the opportunity to make a difference, please send a CV and covering letter outlining your suitability, availability and current salary to:

Sheridan Cook,
Office Manager,
Arecor Limited,
2 Cambridge Science Park,
Cambridge, CB4 0FE

or email: sheridan.cook@arecor.com
NO AGENCIES PLEASE
©Arecor 2009. All rights reserved. Designed & developed by The Refinery